Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05187169 · ClinicalTrials.gov registry record · Phase 1
Food Effect of VS-6766 in Healthy Adult Subjects
A Phase 1 study of Food Effect, sponsored by Verastem.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT05187169 is a Phase 1 study of Food Effect that has completed, run by Verastem. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05187169, a Phase 1 study of Food Effect, has completed, sponsored by Verastem.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
An Open-Label, 2-Way, 2-Period Crossover Study of Orally Administered VS-6766 in Healthy Adult Subjects to Determine the Effect of Food on the Pharmacokinetics of VS-6766
Conditions Studied
Interventions
- DRUG VS-6766
Study Locations (1)
Arizona
- Celerion - Tempe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-12-16 |
| Est. Completion | 2022-04-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05187169
The ClinicalTrials.gov registry entry for NCT05187169 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Verastem, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Food Effect appearing as the primary indexed condition, and to 1 intervention - of which VS-6766 is the first listed.
NCT05187169 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05187169 about?
NCT05187169 is a clinical study titled "Food Effect of VS-6766 in Healthy Adult Subjects". An Open-Label, 2-Way, 2-Period Crossover Study of Orally Administered VS-6766 in Healthy Adult Subjects to Determine the Effect of Food on the Pharmacokinetics of VS-6766
What is the current status of trial NCT05187169?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2021-12-16. Estimated completion is 2022-04-12.
What conditions does trial NCT05187169 study?
This clinical trial studies the following conditions: Food Effect.
What interventions are being tested in trial NCT05187169?
The interventions under investigation include: VS-6766 (DRUG).
Who is sponsoring clinical trial NCT05187169?
This trial is sponsored by Verastem, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05187169 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Food Effect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.